BILTRICIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Biltricide, and when can generic versions of Biltricide launch?
Biltricide is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in BILTRICIDE is praziquantel. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the praziquantel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Biltricide
A generic version of BILTRICIDE was approved as praziquantel by ENDO OPERATIONS on November 27th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BILTRICIDE?
- What are the global sales for BILTRICIDE?
- What is Average Wholesale Price for BILTRICIDE?
Summary for BILTRICIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 146 |
| Clinical Trials: | 9 |
| Patent Applications: | 3,199 |
| Drug Prices: | Drug price information for BILTRICIDE |
| What excipients (inactive ingredients) are in BILTRICIDE? | BILTRICIDE excipients list |
| DailyMed Link: | BILTRICIDE at DailyMed |
Recent Clinical Trials for BILTRICIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kanazawa University | Phase 2/Phase 3 |
| Kenya Medical Research Institute | Phase 2/Phase 3 |
| Terik Essential Programs Agency for Development, Kenya | Phase 2/Phase 3 |
Pharmacology for BILTRICIDE
| Drug Class | Anthelmintic |
US Patents and Regulatory Information for BILTRICIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | BILTRICIDE | praziquantel | TABLET;ORAL | 018714-001 | Dec 29, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BILTRICIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | BILTRICIDE | praziquantel | TABLET;ORAL | 018714-001 | Dec 29, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BILTRICIDE
See the table below for patents covering BILTRICIDE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 1036606 | PROCEDE DE SYNTHESE DE DERIVES D'ACYL-2-OXO-4 PYRAZINO ISOQUINOLINE (2-ACYL-4-OXO-PYRAZINO-ISOQUINOLINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF) | ⤷ Sign Up |
| Japan | S5826352 | ⤷ Sign Up | |
| Hungary | 170858 | SPOSOB POLUCHENIJA 2-ACIL-PROIZVODNYKH 4-OKSO-GEKSAGIDRO-4H-PIRAZINO(2,1-A)IZOKHINOLINA (PROCESS FOR PREPARING DERIVATIVES OF THE 2-ACYL-4-OXO-HEXAHYDRO-4H-PYRAZINO/2,1-A/ISOQUINOLINES) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
